MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
about
MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapyMicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1MicroRNA regulation of human protease genes essential for influenza virus replicationmiR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinomaThe significance of elevated plasma expression of microRNA 106b~25 clusters in gastric cancerOver-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition processDown-regulation of miRNA-106b inhibits growth of melanoma cells by promoting G1-phase cell cycle arrest and reactivation of p21/WAF1/Cip1 protein.MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone.Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment.miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma.A genetic variant in the promoter region of miR-106b-25 cluster predict clinical outcome of HBV-related hepatocellular carcinoma in Chinese.MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47.The effect of antisense inhibitor of miRNA 106b∼25 on the proliferation, invasion, migration, and apoptosis of gastric cancer cell.BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10.miR-106b is overexpressed in medulloblastomas and interacts directly with PTEN.MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN.MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells.MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma.MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer.Integrated Analysis of Dysregulated miRNA-gene Expression in HMGA2-silenced Retinoblastoma CellsHuman ESC self-renewal promoting microRNAs induce epithelial-mesenchymal transition in hepatocytes by controlling the PTEN and TGFβ tumor suppressor signaling pathways.MicroRNA‑503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4.HBeAg-induced miR-106b promotes cell growth by targeting the retinoblastoma gene.miR-106b-responsive gene landscape identifies regulation of Kruppel-like factor family.MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells.Grape seed procyanidin extract against lung cancer: the role of microrna-106b, bioavailability, and bioactivity.miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC.MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers.MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA.
P2860
Q26747068-5F805320-034B-48E4-A926-860B3FC02795Q28384675-70B20223-7F1D-46E0-BBEE-58B8DC8B8B27Q28483683-2435D6FB-3916-4C03-9640-5CAC0A7BF69CQ33661028-997D0C60-12E0-4B8D-8CC8-9D4FDD8C4D73Q33745916-6552AA89-BC7B-41A6-B46E-8EDDB0E57347Q34618415-3861067F-C9F1-4F5F-93E6-A46CF424BCBAQ34786521-4038AA33-B811-4E18-AB0C-D435944EB9E4Q36326306-856748E2-5FD5-4921-B737-89662D203059Q36381117-46467A3E-E7C6-4707-82A1-BBD9D23517E4Q36602355-78342EDF-5764-453E-B2A3-7E08F853F141Q37107802-DC26C561-6E3D-46E5-92E0-2869C1219F0DQ37453234-FB1E21FE-9404-4358-8254-BDD9B9C918D7Q38741604-82C64103-CD19-4730-844F-6BAA8EB86C78Q38796133-87D32CB7-14D0-422B-A711-C3E1E6A51BF5Q38939530-B21039C3-3E21-4EF3-B85F-112DB0C62D50Q38973879-4B174257-F7BC-4710-A2CF-D6B7D81B005FQ38993513-93B33FDB-F006-4DE1-9852-01024BB99050Q39051588-A9A81E94-CCEF-4AD8-9865-EFFE7C0F01CDQ39069313-1986F795-D31E-48B4-BDA6-6B03AD39E7A2Q39255366-37154248-4942-4DCE-9A70-15C63DAE0C9CQ39494968-9D9B67E6-9B65-4375-8468-B7EDD8CDE623Q42094013-072A6629-CC04-436A-8899-9E913EE3A93CQ42590086-A90F761C-8EF4-46FF-9039-8A40D694AB6EQ42678973-64AEE83C-9AF6-45EC-AF54-E24B826D3516Q42951602-BB597F10-82F2-4874-88DF-AC32DD20AD68Q47235299-DAFB20FD-95C7-43C3-9354-54195578F35DQ47867637-1F6E4641-53F5-40B1-942E-E6D980B6BB7AQ52592873-4821CDF0-408A-4794-B7AA-05DED9624C93Q52649778-C82668C6-D8CA-4371-82C6-80E29BDEB15EQ54191921-3A49A74A-EED2-4250-887C-6185507E3EF6Q54244950-191CF12E-2F41-4FE8-9A04-D3628F6476EDQ54252991-11097F6C-53DD-4F86-B4CA-77CD7620FDD4Q55669243-DB3F3448-CD78-4831-A127-E7CD713EB4F7
P2860
MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
@en
type
label
MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
@en
prefLabel
MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
@en
P2093
P2860
P356
P1476
MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma.
@en
P2093
P2860
P2888
P356
10.1186/1756-9966-30-73
P577
2011-08-08T00:00:00Z
P5875
P6179
1031457442